Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Yu · SciRah

Researcher profile · Semantic Scholar

A. Yu

Share profile

A. Yu — researcher profile on SciRah

h-index: 35
Works: 149
Citations: 4,789

Most-cited papers

Comparative Effectiveness Without Head-to-Head Trials
J. Signorovitch, E. Wu, A. Yu, C. Gerrits +4 more
2012PharmacoEconomics (Auckland)372 citations
Semantic Scholar
Systematic review: the costs of ulcerative colitis in Western countries
R. Cohen, A. Yu, E.-Q. Wu, J. Xie +2 more
2010Alimentary Pharmacology and Therapeutics282 citations Open access
Semantic Scholar
The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial.
A. Menter, M. Augustin, J. Signorovitch, A. Yu +4 more
2010Journal of American Academy of Dermatology193 citations
Semantic Scholar
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy
S. Lichtiger, D. Binion, D. Wolf, D. Present +8 more
2010Alimentary Pharmacology and Therapeutics190 citations
Semantic Scholar
Risks of developing psychiatric disorders in pediatric patients with psoriasis.
A. Kimball, E. Wu, A. Guerin, A. Yu +4 more
2012Journal of American Academy of Dermatology187 citations
Semantic Scholar
Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers
A. Yu, A. Guerin, D. Ponce de León, K. Ramakrishnan +4 more
2011Journal of Medical Economics172 citations
Semantic Scholar
Increased Risks of Developing Anxiety and Depression in Young Patients With Crohn's Disease
E. Loftus, A. Guerin, A. Yu, E. Wu +3 more
2011American Journal of Gastroenterology151 citations Open access
Semantic Scholar
Economic burden of comorbidities in patients with psoriasis is substantial
A. Kimball, A. Guerin, M. Tsaneva, A. Yu +4 more
2011Journal of the European Academy of Dermatology and Venereology123 citations
Semantic Scholar
Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis.
A. Kimball, A. Guerin, D. Latremouille-Viau, A. Yu +3 more
2010American Journal of Medicine110 citations
Semantic Scholar
Frequency, Risk, and Cost of Gout-related Episodes Among the Elderly: Does Serum Uric Acid Level Matter?
E. Wu, P. Patel, R. Mody, A. Yu +3 more
2009Journal of Rheumatology95 citations Open access
Semantic Scholar
Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease: Results From the CHARM Trial
J. Colombel, W. Sandborn, P. Rutgeerts, M. Kamm +6 more
2009American Journal of Gastroenterology92 citations
Semantic Scholar
Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease.
M. Jaff, K. Cahill, A. Yu, H. Birnbaum +1 more
2010Annals of Vascular Surgery89 citations
Semantic Scholar
Economic burden of psoriasis compared to the general population and stratified by disease severity
A. Yu, Jackson Tang, Jipan Xie, E. Wu +3 more
2009Current Medical Research and Opinion89 citations
Semantic Scholar
Hypoglycemia, Treatment Discontinuation, and Costs in Patients with Type 2 Diabetes Mellitus on Oral Antidiabetic Drugs
M. Bron, M. Marynchenko, Hong-Bo Yang, A. Yu +1 more
2012Postgraduate medicine84 citations
Semantic Scholar
Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia
E. Wu, A. Guerin, A. Yu, V. Bollu +2 more
2010Current Medical Research and Opinion81 citations
Semantic Scholar
The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis.
A. Kimball, A. Yu, J. Signorovitch, Jipan Xie +4 more
2012Journal of American Academy of Dermatology78 citations
Semantic Scholar
Comorbidity Burden, Healthcare Resource Utilization, and Costs in Chronic Gout Patients Refractory to Conventional Urate-Lowering Therapy
E. Wu, A. Forsythe, A. Guerin, A. Yu +2 more
2012American Journal of Therapeutics74 citations
Semantic Scholar
Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis
A. Yu, Hong-Bo Yang, E. Wu, J. Setyawan +2 more
2011Journal of Medical Economics62 citations Open access
Semantic Scholar
Estimating the effect of medication adherence on health outcomes among patients with type 2 diabetes--an application of marginal structural models.
A. Yu, Yan-Ni F. Yu, M. Nichol
2010Value in Health58 citations Open access
Semantic Scholar
Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD.
A. Yu, A. Guerin, Diego Ponce de León, K. Ramakrishnan +4 more
2011Respiratory Medicine57 citations Open access
Semantic Scholar
Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities
A. Kimball, A. Bensimon, A. Guerin, A. Yu +5 more
2011American Journal of Clinical Dermatology55 citations
Semantic Scholar
Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn’s Disease
A. Yu, Scott J. Johnson, Si-Tien Wang, P. Atanasov +4 more
2012PharmacoEconomics (Auckland)45 citations
Semantic Scholar
High Prevalence of Potential Drug-Drug Interactions for Psoriasis Patients Prescribed Methotrexate or Cyclosporine for Psoriasis: Associated Clinical and Economic Outcomes in Real-World Practice
J. Saurat, A. Guerin, A. Yu, D. Latremouille-Viau +4 more
2010Dermatology44 citations Open access
Semantic Scholar
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial.
K. Reich, J. Signorovitch, K. Ramakrishnan, A. Yu +4 more
2010Journal of American Academy of Dermatology38 citations
Semantic Scholar
Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohn's disease
E. Loftus, Scott J. Johnson, A. Yu, E. Wu +2 more
2009European Journal of Gastroenterology and Hepathology38 citations
Semantic Scholar
Outcomes Associated with Post-Discharge Insulin Continuity in US Patients with Type 2 Diabetes Mellitus Initiating Insulin in the Hospital
E. Wu, Steve Zhou, A. Yu, Mei Lu +3 more
2012Hospital Practice37 citations
Semantic Scholar
Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: Results from the CHARM trial
D. Rubin, P. Mulani, J. Chao, P. Pollack +3 more
2012Inflammatory Bowel Diseases36 citations
Semantic Scholar
Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
Jipan Xie, M. Namjoshi, E. Wu, K. Parikh +4 more
2011Journal of Managed Care Pharmacy34 citations Open access
Semantic Scholar
Asthma Severity Categorization Using a Claims-Based Algorithm or Pulmonary Function Testing
H. Birnbaum, J. Ivanova, A. Yu, M. Hsieh +4 more
2009Journal of Asthma30 citations
Semantic Scholar
Monitoring and switching patterns of patients with chronic myeloid leukemia treated with imatinib in community settings: a chart review analysis
Lei Chen, A. Guerin, Jipan Xie, E. Wu +3 more
2012Current Medical Research and Opinion26 citations
Semantic Scholar
Impact of Adalimumab on Symptoms of Psoriatic Arthritis in Patients with Moderate to Severe Psoriasis: A Pooled Analysis of Randomized Clinical Trials
P. Mease, J. Signorovitch, A. Yu, E. Wu +3 more
2009Dermatology23 citations
Semantic Scholar
Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs
E. Wu, P. Greenberg, E. Yang, A. Yu +2 more
2009Journal of Medical Economics21 citations Open access
Semantic Scholar
Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients
T. Le, K. Winfree, Hong-Bo Yang, M. Marynchenko +3 more
2012Journal of Medical Economics20 citations Open access
Semantic Scholar
Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder
E. Wu, A. Yu, V. Lauzon, K. Ramakrishnan +4 more
2011The Annals of Pharmacotherapy20 citations
Semantic Scholar
Economic impact of switching from valsartan to other angiotensin receptor blockers in patients with hypertension
J. Signorovitch, Jie Zhang, Eric Q. Wu, D. Latremouille-Viau +3 more
2010Current Medical Research and Opinion19 citations
Semantic Scholar
Outcomes associated with insulin therapy disruption after hospital discharge among patients with type 2 diabetes mellitus who had used insulin before and during hospitalization.
E. Wu, Steve Zhou, A. Yu, Mei Lu +3 more
2012Endocrine Practice18 citations
Semantic Scholar
Compliance, Persistence, Healthcare Resource Use, and Treatment Costs Associated with Aliskiren plus ARB versus ACE Inhibitor plus ARB Combination Therapy
Joanne R Chang, Weiyi Yang, K. Kahler, Thomas Fellers +5 more
2011American Journal of Cardiovascular Drugs17 citations
Semantic Scholar
Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy
Weiyi Yang, K. Kahler, Thomas Fellers, J. Orloff +5 more
2011Journal of Medical Economics16 citations Open access
Semantic Scholar
Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD
Shawn X. Sun, M. Marynchenko, R. Banerjee, David Cheng +4 more
2011Journal of Medical Economics16 citations
Semantic Scholar
A longitudinal analysis of costs associated with change in disease activity in systemic lupus erythematosus
H. Kan, A. Guerin, M. Kaminsky, A. Yu +5 more
2013Journal of Medical Economics15 citations Open access
Semantic Scholar
Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: a retrospective database analysis.
Lauren J. Lee, A. Yu, Scott J. Johnson, H. Birnbaum +4 more
2010Diabetes Research and Clinical Practice15 citations
Semantic Scholar
Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievement
Joanne R Chang, Weiyi Yang, Thomas Fellers, K. Kahler +5 more
2010Current Medical Research and Opinion14 citations
Semantic Scholar
Effects of Adalimumab versus Placebo on Risk of Symptom Worsening in Psoriasis and Subsequent Impacts on Health-Related Quality-of-Life
K. Papp, J. Signorovitch, K. Ramakrishnan, A. Yu +3 more
2011Clinical drug investigation12 citations
Semantic Scholar
Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors
J. Signorovitch, K. Ramakrishnan, R. Ben-Hamadi, A. Yu +3 more
2011Current Medical Research and Opinion12 citations
Semantic Scholar
Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancer
Hong-Bo Yang, A. Yu, E. Wu, Y. Yim +1 more
2011Journal of Medical Economics11 citations Open access
Semantic Scholar
Resource utilization and costs of schizophrenia patients treated with olanzapine versus quetiapine in a Medicaid population.
A. Yu, P. Atanasov, R. Ben-Hamadi, H. Birnbaum +2 more
2009Value in Health10 citations Open access
Semantic Scholar
Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus
B. Pandya, M. Bron, T. McCall, A. Yu +3 more
2011Current Medical Research and Opinion8 citations
Semantic Scholar
Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasons
E. Wu, R. Ben-Hamadi, A. Yu, Jackson Tang +2 more
2010Journal of Medical Economics8 citations
Semantic Scholar
41a Prediction of Long-Term Clinical Remission for Adalimumab-Treated Patients With Crohn's Disease by Identification of Appropriate Dichotomizing Points for SES-CD
W. Reinisch, P. Rutgeerts, R. Panaccione, G. D'Haens +8 more
20108 citations
Semantic Scholar
Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population.
A. Yu, R. Ben-Hamadi, H. Birnbaum, P. Atanasov +2 more
2009Current Medical Research and Opinion8 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Wu×37
Invite
E. Wu — researcher profile on SciRah
P. Mulani×20
Invite
P. Mulani — researcher profile on SciRah
Y. Bao×12
Invite
Y. Bao — researcher profile on SciRah
Shiraz R. Gupta×12
Invite
Shiraz R. Gupta — researcher profile on SciRah

×12

Invite

A. Guerin — researcher profile on SciRah

J. Signorovitch×8

Invite

J. Signorovitch — researcher profile on SciRah

Invite

J. Chao — researcher profile on SciRah

K. Ramakrishnan×6

Invite

K. Ramakrishnan — researcher profile on SciRah

R. Ben-Hamadi×6

Invite

R. Ben-Hamadi — researcher profile on SciRah

Invite

A. Bensimon — researcher profile on SciRah

Invite

A. Kimball — researcher profile on SciRah

Invite

M. Tsaneva — researcher profile on SciRah